Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06939478 · ClinicalTrials.gov registry record
AI Powered Mapping Technology for Identifying Arrhythmias
A clinical trial of Arrhythmias, Cardiac, sponsored by Heart Rhythm Clinical and Research Solutions.
- Recruiting
- Registry status
- 110
- Enrollment target
- 5
- Study locations
NCT06939478: Recruiting study of Arrhythmias, Cardiac, sponsored by Heart Rhythm Clinical and Research Solutions.
NCT06939478 is a study of Arrhythmias, Cardiac that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 110 participants, below the 556-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target (80% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06939478, a study of Arrhythmias, Cardiac, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 5
- Study locations
Study Summary
Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.
Primary Outcome
AF termination or AF non-inducibility in AF ablation cases
Conditions Studied
Interventions
- DEVICE Arrhythmia Mapping
Study Locations (5)
Florida
- Ascension St. Vincent's - Jacksonville
- HCA Florida Healthcare - Miami
Alabama
- Grandview Medical Center - Birmingham
Ohio
- OhioHealth - Columbus
Pennsylvania
- Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-08-27 |
| Est. Completion | 2025-12 |
What NCT06939478 shows while recruiting
NCT06939478 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 556-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Arrhythmias, Cardiac appearing as the primary indexed condition, and to 1 intervention - of which Arrhythmia Mapping is the first listed.
NCT06939478 lists 5 locations in 4 states (Florida, Alabama, Ohio).
Frequently Asked Questions
What is clinical trial NCT06939478 about?
NCT06939478 is a clinical study titled "AI Powered Mapping Technology for Identifying Arrhythmias". Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.
What is the current status of trial NCT06939478?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2025-08-27. Estimated completion is 2025-12.
What conditions does trial NCT06939478 study?
This clinical trial studies the following conditions: Arrhythmias, Cardiac.
What interventions are being tested in trial NCT06939478?
The interventions under investigation include: Arrhythmia Mapping (DEVICE).
Who is sponsoring clinical trial NCT06939478?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06939478 being conducted?
This trial has 5 study locations across Alabama, Florida, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arrhythmias, Cardiac
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06939478's enrollment target sits among peer trials
110 13th of 17 higher than 5 of 17 other Arrhythmias, Cardiac trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arrhythmias, Cardiac trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
RECRUITING
-
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
RECRUITING · NA
-
Machine Learning in Atrial Fibrillation
RECRUITING
-
Cardiac Implantable Electronic Device (CIED) Research Study
ACTIVE NOT RECRUITING
-
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI